Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund

Plus, news about Phath­om and CAN­bridge:

Avid­i­ty Bio­sciences clos­es $345.1M of­fer­ing: The raise comes on the heels of Phase 1/2 da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.